Tela Bio Inc Expected To Post A Loss Of 18 Cents A Share: Earnings Preview

TELA Bio

07/08/2026 22:53

TELA Bio Inc TELA.OQ TELA.O is expected to  show a fall in quarterly revenue when it reports  results on August 10 for the period ending June 30 2026
The Malvern Pennsylvania-based  company is expected to report a 0.9% decrease in revenue to $20.008 million from $20.2 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.The company's guidance on May 12 2026, for the period ended June 30, was for revenue of $20.000 million.
​LSEG's mean analyst estimate for TELA Bio Inc is for a loss of 18 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for TELA Bio Inc is $2.00, about 132.6% above its last closing price of $0.86
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.19
-0.19
-0.21
Missed
-11.6
Dec. 31 2026
-0.19
-0.18
-0.17
Beat
6.9
Sep. 30 2025
-0.20
-0.20
-0.19
Beat
4.5​
Jun. 30 2025
-0.18
-0.18
-0.22
Missed
-24.4
​​Mar. 31 2025
-0.20
-0.20
-0.25
Missed
-27.8
Dec. 31 2024
-0.24
-0.22
-0.23
Missed
-3.2​
Sep. 30 2024
-0.42
-0.40
-0.42
Missed
-3.9
Jun. 30 2024
-0.46
-0.47
-0.51
Missed
-8.1
This summary was machine generated August 7 at 21:53 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)